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 Decarboxylation and decarbonylation are important reactions in synthetic organic 
chemistry, transforming readily available carboxylic acids and their derivatives into various 
products through loss of carbon dioxide or carbon monoxide.  In the past few decades, palladium-
catalyzed decarboxylative and decarbonylative reactions experienced tremendous growth due to 
the excellent catalytic activity of palladium.  Development of new reactions in this category for 
fine and commodity chemical synthesis continues to draw attention from the chemistry 
community. 
 The Stoltz laboratory has established a palladium-catalyzed enantioselective 
decarboxylative allylic alkylation of β-keto esters for the synthesis of α-quaternary ketones since 
2005.  Recently, we extended this chemistry to lactams due to the ubiquity and importance of 
nitrogen-containing heterocycles.  A wide variety of α-quaternary and tetrasubstituted α-tertiary 
lactams were obtained in excellent yields and exceptional enantioselectivities using our 
palladium-catalyzed decarboxylative allylic alkylation chemistry.  Enantioenriched α-quaternary 
carbonyl compounds are versatile building blocks that can be further elaborated to intercept 
synthetic intermediates en route to many classical natural products.  Thus our chemistry enables 
catalytic asymmetric formal synthesis of these complex molecules. 
 In addition to fine chemicals, we became interested in commodity chemical synthesis 
using renewable feedstocks.  In collaboration with the Grubbs group, we developed a palladium-
catalyzed decarbonylative dehydration reaction that converts abundant and inexpensive fatty 
acids into value-added linear alpha olefins.  The chemistry proceeds under relatively mild 
conditions, requires very low catalyst loading, tolerates a variety of functional groups, and is 
easily performed on a large scale.  An additional advantage of this chemistry is that it provides 
access to expensive odd-numbered alpha olefins. 
 Finally, combining features of both projects, we applied a small-scale decarbonylative 
dehydration reaction to the synthesis of α-vinyl carbonyl compounds.  Direct α-vinylation is 
challenging, and asymmetric vinylations are rare.  Taking advantage of our decarbonylative 
dehydration chemistry, we were able to transform enantioenriched δ-oxocarboxylic acids into 
quaternary α-vinyl carbonyl compounds in good yields with complete retention of 
stereochemistry.  Our explorations culminated in the catalytic enantioselective total synthesis of 
(–)-aspewentin B, a terpenoid natural product featuring a quaternary α-vinyl ketone.  Both 
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LIST OF ABBREVIATIONS 
Å Ångstrom 
[α]D specific rotation at wavelength of sodium D line 
Ac  acetyl 
APCI atmospheric pressure chemical ionization 
app  apparent 
aq aqueous 
Ar aryl 
atm  atmosphere 
BBN borabicyclononane 
BINAP 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl 
Bn  benzyl 
Boc  tert-butyloxycarbonyl 
br  broad 
Bu  butyl 
i-Bu    iso-butyl 
t-Bu   tert-Butyl 
Bz benzoyl 
c  concentration for specific rotation measurements 
°C  degrees Celsius 
calc’d  calculated 
cat catalytic 
Cbz carbobenzyloxy 
CCDC  Cambridge Crystallographic Data Centre 
CI  chemical ionization 
Cy  cyclohexyl 




dba  dibenzylideneacetone 
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TEMPO 2,2,6,6-Tetramethylpiperidin-1-yloxy 
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